[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Status, Trends and COVID-19 Impact Report 2022

August 2022 | 120 pages | ID: GF424CEC947BEN
BisReport Information Consulting CO., Ltd

US$ 2,350.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
In the past few years, the Glucagon Like Peptide-1 (GLP-1) Agonists market experienced a huge change under the influence of COVID-19, the global market size of Glucagon Like Peptide-1 (GLP-1) Agonists reached 8816.19 million $ in 2021 from xx in 2016 with a CAGR of xx from 2016-2021 is. As of now, the global COVID-19 Coronavirus Cases have exceeded 500 million, and the global epidemic has been basically under control, therefore, the World Bank has estimated the global economic growth in 2021 and 2022. The World Bank predicts that the global economic output is expected to expand 4 percent in 2021 while 3.8 percent in 2022. According to our research on Glucagon Like Peptide-1 (GLP-1) Agonists market and global economic environment, we forecast that the global market size of Glucagon Like Peptide-1 (GLP-1) Agonists will reach 16440.0 million $ in 2027 with a CAGR of % from 2022-2027.

Due to the COVID-19 pandemic, according to World Bank statistics, global GDP has shrunk by about 3.5% in 2020. Entering 2021, Economic activity in many countries has started to recover and partially adapted to pandemic restrictions. The research and development of vaccines has made breakthrough progress, and many governments have also issued various policies to stimulate economic recovery, particularly in the United States, is likely to provide a strong boost to economic activity but prospects for sustainable growth vary widely between countries and sectors. Although the global economy is recovering from the great depression caused by COVID-19, it will remain below pre-pandemic trends for a prolonged period. The pandemic has exacerbated the risks associated with the decade-long wave of global debt accumulation. It is also likely to steepen the long-expected slowdown in potential growth over the next decade.

The world has entered the COVID-19 epidemic recovery period. In this complex economic environment, we published the Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Status, Trends and COVID-19 Impact Report 2022, which provides a comprehensive analysis of the global Glucagon Like Peptide-1 (GLP-1) Agonists market , This Report covers the manufacturer data, including: sales volume, price, revenue, gross margin, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows the regional development status, including market size, volume and value, as well as price data. Besides, the report also covers segment data, including: type wise, industry wise, channel wise etc. all the data period is from 2016-2021, this report also provide forecast data from 2022-2027.

Section 1: 100 USD——Market Overview

Section (2 3): 1200 USD——Manufacturer Detail
Novo Nordisk
AstraZeneca
Eli Lily
GSK
Sanofi
Bristol-Myers Squibb
Amylin

Section 4: 900 USD——Region Segmentation
North America (United States, Canada, Mexico)
South America (Brazil, Argentina, Other)
Asia Pacific (China, Japan, India, Korea, Southeast Asia)
Europe (Germany, UK, France, Spain, Italy)
Middle East and Africa (Middle East, Africa)

Section (5 6 7): 700 USD——
Product Type Segmentation
Exenatied
Liraglutide
Lixisenatide
Albiglutide
Dulaglutide

Application Segmentation
Hospital
Pharmacy

Channel (Direct Sales, Distribution Channel) Segmentation

Section 8: 500 USD——Market Forecast (2022-2027)

Section 9: 600 USD——Downstream Customers

Section 10: 200 USD——Raw Material and Manufacturing Cost

Section 11: 500 USD——Conclusion

Section 12: Research Method and Data Source
SECTION 1 GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MARKET OVERVIEW

1.1 Glucagon Like Peptide-1 (GLP-1) Agonists Market Scope
1.2 COVID-19 Impact on Glucagon Like Peptide-1 (GLP-1) Agonists Market
1.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Status and Forecast Overview
  1.3.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Status 2016-2021
  1.3.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast 2022-2027

SECTION 2 GLOBAL GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MARKET MANUFACTURER SHARE

2.1 Global Manufacturer Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume
2.2 Global Manufacturer Glucagon Like Peptide-1 (GLP-1) Agonists Business Revenue

SECTION 3 MANUFACTURER GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS BUSINESS INTRODUCTION

3.1 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Business Introduction
  3.1.1 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Price, Revenue and Gross margin 2016-2021
  3.1.2 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Business Distribution by Region
  3.1.3 Novo Nordisk Interview Record
  3.1.4 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Business Profile
  3.1.5 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Product Specification
3.2 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Business Introduction
  3.2.1 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Price, Revenue and Gross margin 2016-2021
  3.2.2 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Business Distribution by Region
  3.2.3 Interview Record
  3.2.4 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Business Overview
  3.2.5 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Product Specification
3.3 Manufacturer three Glucagon Like Peptide-1 (GLP-1) Agonists Business Introduction
  3.3.1 Manufacturer three Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Price, Revenue and Gross margin 2016-2021
  3.3.2 Manufacturer three Glucagon Like Peptide-1 (GLP-1) Agonists Business Distribution by Region
  3.3.3 Interview Record
  3.3.4 Manufacturer three Glucagon Like Peptide-1 (GLP-1) Agonists Business Overview
  3.3.5 Manufacturer three Glucagon Like Peptide-1 (GLP-1) Agonists Product Specification

SECTION 4 GLOBAL GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MARKET SEGMENTATION (BY REGION)

4.1 North America Country
  4.1.1 United States Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Price Analysis 2016-2021
  4.1.2 Canada Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Price Analysis 2016-2021
  4.1.3 Mexico Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Price Analysis 2016-2021
4.2 South America Country
  4.2.1 Brazil Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Price Analysis 2016-2021
  4.2.2 Argentina Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Price Analysis 2016-2021
4.3 Asia Pacific
  4.3.1 China Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Price Analysis 2016-2021
  4.3.2 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Price Analysis 2016-2021
  4.3.3 India Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Price Analysis 2016-2021
  4.3.4 Korea Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Price Analysis 2016-2021
  4.3.5 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Price Analysis 2016-2021
4.4 Europe Country
  4.4.1 Germany Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Price Analysis 2016-2021
  4.4.2 UK Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Price Analysis 2016-2021
  4.4.3 France Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Price Analysis 2016-2021
  4.4.4 Spain Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Price Analysis 2016-2021
  4.4.5 Italy Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Price Analysis 2016-2021
4.5 Middle East and Africa
  4.5.1 Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Price Analysis 2016-2021
  4.5.2 Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Price Analysis 2016-2021
4.6 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Segmentation (By Region) Analysis 2016-2021
4.7 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Segmentation (By Region) Analysis

SECTION 5 GLOBAL GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MARKET SEGMENTATION (BY PRODUCT TYPE)

5.1 Product Introduction by Type
  5.1.1 Exenatied Product Introduction
  5.1.2 Liraglutide Product Introduction
  5.1.3 Lixisenatide Product Introduction
  5.1.4 Albiglutide Product Introduction
  5.1.5 Dulaglutide Product Introduction
5.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume by Liraglutide016-2021
5.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Liraglutide016-2021
5.4 Different Glucagon Like Peptide-1 (GLP-1) Agonists Product Type Price 2016-2021
5.5 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Segmentation (By Type) Analysis

SECTION 6 GLOBAL GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MARKET SEGMENTATION (BY APPLICATION)

6.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume by Application 2016-2021
6.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Application 2016-2021
6.2 Glucagon Like Peptide-1 (GLP-1) Agonists Price in Different Application Field 2016-2021
6.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Segmentation (By Application) Analysis

SECTION 7 GLOBAL GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MARKET SEGMENTATION (BY CHANNEL)

7.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Segmentation (By Channel) Sales Volume and Share 2016-2021
7.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Segmentation (By Channel) Analysis

SECTION 8 GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MARKET FORECAST 2022-2027

8.1 Glucagon Like Peptide-1 (GLP-1) Agonists Segmentation Market Forecast 2022-2027 (By Region)
8.2 Glucagon Like Peptide-1 (GLP-1) Agonists Segmentation Market Forecast 2022-2027 (By Type)
8.3 Glucagon Like Peptide-1 (GLP-1) Agonists Segmentation Market Forecast 2022-2027 (By Application)
8.4 Glucagon Like Peptide-1 (GLP-1) Agonists Segmentation Market Forecast 2022-2027 (By Channel)
8.5 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price Forecast

SECTION 9 GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS APPLICATION AND CLIENT ANALYSIS

9.1 Hospital Customers
9.2 Pharmacy Customers

SECTION 10 GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MANUFACTURING COST OF ANALYSIS

11.0 Raw Material Cost Analysis
11.0 Labor Cost Analysis
11.0 Cost Overview

SECTION 11 CONCLUSION

SECTION 12 METHODOLOGY AND DATA SOURCE

CHART AND FIGURE

Figure Glucagon Like Peptide-1 (GLP-1) Agonists Product Picture
Chart Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (with or without the impact of COVID-19)
Chart Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (Units) and Growth Rate 2016-2021
Chart Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (Million $) and Growth Rate 2016-2021
Chart Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (Units) and Growth Rate 2022-2027
Chart Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (Million $) and Growth Rate 2022-2027
Chart 2016-2021 Global Manufacturer Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (Units)
Chart 2016-2021 Global Manufacturer Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Share
Chart 2016-2021 Global Manufacturer Glucagon Like Peptide-1 (GLP-1) Agonists Business Revenue (Million USD)
Chart 2016-2021 Global Manufacturer Glucagon Like Peptide-1 (GLP-1) Agonists Business Revenue Share
Chart Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Price, Revenue and Gross margin 2016-2021
Chart Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Business Distribution
Chart Novo Nordisk Interview Record (Partly)
Chart Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Business Profile
Table Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Product Specification
Chart AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Price, Revenue and Gross margin 2016-2021
Chart AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Business Distribution
Chart AstraZeneca Interview Record (Partly)
Chart AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Business Overview
Table AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Product Specification
Chart United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price (USD/Unit) 2016-2021
Chart Canada Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Canada Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price (USD/Unit) 2016-2021
Chart Mexico Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Mexico Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price (USD/Unit) 2016-2021
Chart Brazil Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Brazil Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price (USD/Unit) 2016-2021
Chart Argentina Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Argentina Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price (USD/Unit) 2016-2021
Chart China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price (USD/Unit) 2016-2021
Chart Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price (USD/Unit) 2016-2021
Chart India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price (USD/Unit) 2016-2021
Chart Korea Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Korea Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price (USD/Unit) 2016-2021
Chart Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price (USD/Unit) 2016-2021
Chart Germany Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Germany Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price (USD/Unit) 2016-2021
Chart UK Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart UK Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price (USD/Unit) 2016-2021
Chart France Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart France Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price (USD/Unit) 2016-2021
Chart Spain Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Spain Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price (USD/Unit) 2016-2021
Chart Italy Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Italy Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price (USD/Unit) 2016-2021
Chart Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price (USD/Unit) 2016-2021
Chart Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price (USD/Unit) 2016-2021
Chart Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Segmentation Sales Volume (Units) by Region 2016-2021
Chart Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Segmentation Sales Volume (Units) Share by Region 2016-2021
Chart Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Segmentation Market size (Million $) by Region 2016-2021
Chart Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Segmentation Market size (Million $) Share by Region 2016-2021
Chart Exenatied Product Figure
Chart Exenatied Product Description
Chart Liraglutide Product Figure
Chart Liraglutide Product Description
Chart Lixisenatide Product Figure
Chart Lixisenatide Product Description
Chart Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (Units) by Liraglutide016-2021
Chart Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (Units) Share by Type
Chart Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (Million $) by Liraglutide016-2021
Chart Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (Million $) Share by Liraglutide016-2021
Chart Different Glucagon Like Peptide-1 (GLP-1) Agonists Product Type Price ($/Unit) 2016-2021
Chart Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (Units) by Application 2016-2021
Chart Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (Units) Share by Application
Chart Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (Million $) by Application 2016-2021
Chart Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (Million $) Share by Application 2016-2021
Chart Glucagon Like Peptide-1 (GLP-1) Agonists Price in Different Application Field 2016-2021
Chart Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Segmentation (By Channel) Sales Volume (Units) 2016-2021
Chart Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Segmentation (By Channel) Share 2016-2021
Chart Glucagon Like Peptide-1 (GLP-1) Agonists Segmentation Market Sales Volume (Units) Forecast (by Region) 2022-2027
Chart Glucagon Like Peptide-1 (GLP-1) Agonists Segmentation Market Sales Volume Forecast (By Region) Share 2022-2027
Chart Glucagon Like Peptide-1 (GLP-1) Agonists Segmentation Market Size (Million USD) Forecast (By Region) 2022-2027
Chart Glucagon Like Peptide-1 (GLP-1) Agonists Segmentation Market Size Forecast (By Region) Share 2022-2027
Chart Glucagon Like Peptide-1 (GLP-1) Agonists Market Segmentation (By Type) Volume (Units) 2022-2027
Chart Glucagon Like Peptide-1 (GLP-1) Agonists Market Segmentation (By Type) Volume (Units) Share 2022-2027
Chart Glucagon Like Peptide-1 (GLP-1) Agonists Market Segmentation (By Type) Market Size (Million $) 2022-2027
Chart Glucagon Like Peptide-1 (GLP-1) Agonists Market Segmentation (By Type) Market Size (Million $) 2022-2027
Chart Glucagon Like Peptide-1 (GLP-1) Agonists Market Segmentation (By Application) Market Size (Volume) 2022-2027
Chart Glucagon Like Peptide-1 (GLP-1) Agonists Market Segmentation (By Application) Market Size (Volume) Share 2022-2027
Chart Glucagon Like Peptide-1 (GLP-1) Agonists Market Segmentation (By Application) Market Size (Value) 2022-2027
Chart Glucagon Like Peptide-1 (GLP-1) Agonists Market Segmentation (By Application) Market Size (Value) Share 2022-2027
Chart Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Segmentation (By Channel) Sales Volume (Units) 2022-2027
Chart Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Segmentation (By Channel) Share 2022-2027
Chart Global Glucagon Like Peptide-1 (GLP-1) Agonists Price Forecast 2022-2027
Chart Hospital Customers
Chart Pharmacy Customers


More Publications